Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals

Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals

Abstract Cladribine tablets have been granted marketing authorization in Europe and approved by the Food and Drug Administration (FDA) in the USA to treat relapsing forms of multiple sclerosis (MS). However, people with MS (PwMS) may be more familiar, and therefore more confident, with treatments re...

Full description

Bibliographic Details
Main Authors: Ardra Shephard, Laura Kolaczkowski, Noreen Barker, Donna Nahal, Celia Oreja-Guevara, Saúl Reyes, Helen Gray, Hashem Salloukh, Gavin Giovannoni
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-05-01
Series:Neurology and Therapy
Subjects:
Cladribine tablets
Disease-modifying therapy
Education
Multiple sclerosis
Personalized care
Health literacy
Online Access:https://doi.org/10.1007/s40120-024-00608-7

Internet

https://doi.org/10.1007/s40120-024-00608-7

Similar Items